ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

AFFX Affymetrix, Inc.

14.01
0.00 (0.00%)
09 Aug 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Affymetrix, Inc. NASDAQ:AFFX NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 14.01 0 01:00:00

Affymetrix to Webcast Presentation at the Robert W. Baird 2005 Growth Stock Conference

04/05/2005 12:00am

PR Newswire (US)


Affymetrix (NASDAQ:AFFX)
Historical Stock Chart


From Aug 2019 to Aug 2024

Click Here for more Affymetrix Charts.
Affymetrix to Webcast Presentation at the Robert W. Baird 2005 Growth Stock Conference SANTA CLARA, Calif., May 3 /PRNewswire-FirstCall/ -- Affymetrix, Inc. (NASDAQ:AFFX) today announced that Greg Schiffman, Executive Vice President and CFO, will provide a company overview at the Robert W. Baird 2005 Growth Stock Conference at the Four Seasons Hotel in Chicago. A live transmission of the presentation will take place at 11:25 a.m. CDT/ 9:25 a.m. PDT on Tuesday, May 10, 2005. An archived webcast will be available for 30 days. A live webcast of the presentation can be accessed by visiting the Investor Relations section of the Company's website at http://www.affymetrix.com/. About Affymetrix Affymetrix scientists invented the world's first microarray in 1989 and began selling the first commercial microarray in 1994. Since then, Affymetrix GeneChip(R) technology has become the industry standard in molecular biology research. Affymetrix technology is used by the world's top pharmaceutical, diagnostic and biotechnology companies as well as leading academic, government and not-for-profit research institutes. More than 1,200 systems have been shipped around the world and nearly 3,000 peer-reviewed papers have been published using the technology. Affymetrix' patented photolithographic manufacturing process provides the most information capacity available today on an array, enabling researchers to use a whole-genome approach to analyze the relationship between genetics and health. Headquartered in Santa Clara, California, Affymetrix has subsidiaries in Europe and Asia in addition to manufacturing facilities in Sacramento, California and Bedford, Massachusetts. The Company has about 900 employees worldwide. DATASOURCE: Affymetrix, Inc. CONTACT: Doug Farrell, Vice President of Investor Relations of Affymetrix, Inc., +1-408-731-5285 Web site: http://www.affymetrix.com/

Copyright

1 Year Affymetrix Chart

1 Year Affymetrix Chart

1 Month Affymetrix Chart

1 Month Affymetrix Chart

Your Recent History

Delayed Upgrade Clock